DMIIR
Drugs Made In America Acquisition II Corp.
NASDAQ · Financial Services · Asset Management · US
$0.07
−11.07%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.33x
- PEG TTM
- —
- Price / book
- 0.01x
- Price / sales
- —
- Price / cash flow
- -4.30x
Enterprise value
- Enterprise value
- $4.6M
- EV / sales
- —
- EV / EBITDA
- -3.47x
- EV / EBIT
- -3.21x
- Market cap
- $4.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026